Zobrazeno 1 - 10 of 62 pro vyhledávání: '"G J, Weverling"'
1
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
Autor: Valériane, Leroy, Charlotte, Sakarovitch, Mario, Cortina-Borja, James, McIntyre, Hoosen, Coovadia, Francois, Dabis, Marie-Louise, Newell, J, Saba, G, Gray, Ch, Ndugwa, Ch, Kilewo, A, Massawe, P, Kituuka, P, Okong, A, Grulich, H, von Briesen, J, Goudsmit, G, Biberfeld, G, Haverkamp, G J, Weverling, J M A, Lange
Publikováno v: Scopus-Elsevier
AIDS (London, England), 19(16), 1865-1875. Lippincott Williams and Wilkins
There are positive reports about the ability of antiretroviral agents to prevent mother-to-child transmission (MTCT) of HIV. The authors undertook a pooled analysis of African breast-feeding mothers from clinical trials of various antiretroviral regi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3016cd3c49dabf215344ecccaa52a301
https://doi.org/10.1097/01.aids.0000188423.02786.55
Zobrazit plný text záznamu
2
Free fatty acids increase hepatic glycogen content in obese males
Autor: G. Allick, H. P. Sauerwein, M. T. Ackermans, Johannes A. Romijn, Fleur Sprangers, P.H.L.T. Bisschop, G. J. Weverling, E. Endert, A.J. Meijer
Publikováno v: Metabolism: clinical and experimental, 53(7), 886-893. W.B. Saunders Ltd
Obesity is associated with increased hepatic glycogen content. In vivo and in vitro data suggest that plasma free fatty acids (FFA) may cause this increase. In this study we investigated the effect of physiological plasma FFA levels on hepatic glycog
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6008b436a5f6a27f96a1c384bbbd01fd
https://doi.org/10.1016/j.metabol.2004.01.012
Zobrazit plný text záznamu
3
AIDS vaccines that allow HIV-1 to infect and escape immunologic control - A mathematic analysis of mass vaccination
Autor: Jaap Goudsmit, G. J. Weverling, Marijn van Ballegooijen, Johannes A. Bogaards, Maarten C. Boerlijst
Publikováno v: Journal of acquired immune deficiency syndromes (1999), 34(2), 214-220. Lippincott Williams and Wilkins
Bogaards, J A, Van Ballegooijen, M, Weverling, G J, Boerlijst, M C & Goudsmit, J 2003, ' AIDS vaccines that allow HIV-1 to infect and escape immunologic control : A mathematic analysis of mass vaccination ', Journal of Acquired Immune Deficiency Syndromes, vol. 34, no. 2, pp. 214-220 . https://doi.org/10.1097/00126334-200310010-00012
Journal of Acquired Immune Deficiency Syndromes, 34(2), 214-220
Cytotoxic T lymphocyte (CTL)-based HIV vaccine concepts shown to reduce viremia and postpone disease but not to prevent infection in monkeys are currently in human phase 1 trials. To evaluate the potential efficacy of vaccines that cannot prevent HIV
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e5c61cac2f4a81c61ab2bfb9aad0e4
https://doi.org/10.1097/00126334-200310010-00012
Zobrazit plný text záznamu
4
Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort
Autor: Frank de Wolf, Jeanne P. Dieleman, Inge C. Gyssens, Kees Brinkman, Peter Reiss, Bruno H. Stricker, Joep M. A. Lange, G. J. Weverling, Wilhelmina M. C. Mulder, Miriam C. J. M. Sturkenboom, Marielle Jambroes
Publikováno v: AIDS (London, England), 16(5), 737-745. Lippincott Williams and Wilkins
AIDS, 16, 737-745. Lippincott Williams & Wilkins
Background: Toxicity is the most important reason for premature switching of highly active antiretroviral therapy (HAART). In order to optimize the benefit-risk ratio of HAART, guidelines for toxicity management are needed. Objective: An observationa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2a90e94ffc31f67195b58b91bd5da1
https://doi.org/10.1097/00002030-200203290-00009
Zobrazit plný text záznamu
5
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains
Autor: Jaap Goudsmit, Maarten C. Boerlijst, J. M. A. Lange, Frank Miedema, L. van der Hoek, R. A. Coutinho, G. J. Weverling, A. de Ronde
Publikováno v: AIDS (London, England), 15(17), 2293-2301. Lippincott Williams and Wilkins
Objective: Because maintenance of treatment success in HIV-1 infection requires viruses to remain therapy sensitive in drug-naive seropositive persons, we looked at the primary infections caused by drug-resistant HIV-1 over time. Furthermore, to stud
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3270c5edb505b5377efe636cb1f16269
https://doi.org/10.1097/00002030-200111230-00011
Zobrazit plný text záznamu
6
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection
Autor: Ferdinand W. N. M. Wit, Elisabeth H. Gisolf, A. Japour, G. J. Weverling, Peter Reiss, M. van der Valk, S. A. Danner
Publikováno v: AIDS, 15(7), 847-855. Lippincott Williams and Wilkins
AIDS (London, England), 15(7), 847-855. Lippincott Williams and Wilkins
Van Der Valk, M, Gisolf, E H, Reiss, P, Wit, F W N M, Japour, A, Weverling, G J & Danner, S A 2001, ' Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection ', AIDS, vol. 15, no. 7, pp. 847-855 . https://doi.org/10.1097/00002030-200105040-00005
Background: Changes in body fat distribution are an adverse effect of therapy with HIV protease inhibitors (PI). It has been suggested that nucleoside analogue reverse transcriptase inhibitors (NRTI) may also contribute to this so-called lipodystroph
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce311c0eed3cc5023f80753365eb751
https://doi.org/10.1097/00002030-200105040-00005
Zobrazit plný text záznamu
7
A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients
Autor: Kiat Ruxrungtham, J. M. A. Lange, Eugene Kroon, Chaiwat Ungsedhapand, R. Van Leeuwen, G. J. Weverling, Supranee Buranapraditkun, Somsong Teeratakulpisarn, Praphan Phanuphak, David A. Cooper, Sasiwimol Ubolyam, Chaiyos Kunanusont
Publikováno v: AIDS (London, England), 14(10), 1375-1382. Lippincott Williams and Wilkins
To evaluate the safety and efficacy of four different regimens of didanosine (ddI) + stavudine (d4T) in HIV-infected Thais. Prospective, open-label, randomized study. Patients were randomized to four regimens of high and low doses of ddI and d4T or t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be7b7ec2b484cc19f5b3f86a97fefb9
https://doi.org/10.1097/00002030-200007070-00010
Zobrazit plný text záznamu
8
Risk Factors for Human Herpesvirus 8 Seropositivity and Seroconversion in a Cohort of Homosexula Men
Autor: Nicole H. T. M. Dukers, Thomas F. Schulz, Roel A. Coutinho, Maria Prins, Ronald B. Geskus, Neil Renwick, Jaap Goudsmit, G. J. Weverling
Publikováno v: American Journal of Epidemiology. 151:213-224
Sexual and nonsexual modes of transmission of human herpesvirus 8 (HHV8) have been suggested, but specific routes remain unclear. Therefore, the objective of this study was to assess risk factors for HHV8 seropositivity and determine specific sexual
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f693b0332dbdc04824ad1ae2b2bcced2
https://doi.org/10.1093/oxfordjournals.aje.a010195
Zobrazit plný text záznamu
9
Short Communication: Cellular Proviral HIV Type 1 DNA Load Persists after Long-Term RT-Inhibitor Therapy in HIV Type 1 Infected Persons
Autor: Peter Reiss, G. J. Weverling, Sylvia M. Bruisten, Charles A. Boucher, J. G. Huisman, A. E. Loeliger, P. Van Swieten, Rob Schuurman
Publikováno v: AIDS Research and Human Retroviruses. 14:1053-1058
In a set of 42 antiretroviral naive HIV-1 infected persons who were treated with either Zidovudine (AZT) monotherapy, or a combination of AZT + ddC (Zalcitabine) or AZT + ddl (Didanosine),...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79cf6d046b597571f6787e787b5eb1c9
https://doi.org/10.1089/aid.1998.14.1053
Zobrazit plný text záznamu
10
The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy
Autor: F. De Wolf, G. J. Weverling, R. M. W. Hoetelmans, R. W. ten Kate, J. W. Mulder, Jos H. Beijnen, H. M. Weigel, P. H. J. Frissen, Marijke T. L. Roos, J. M. A. Lange, Hanneke Schuitemaker, Suzanne Jurriaans, M. H. E. Reijers, Ferdinand W. N. M. Wit
Publikováno v: AIDS (London, England), 12(11), F111-F115. Lippincott Williams and Wilkins
Objective: To investigate the relationship between exposure to antiretroviral drugs and the initial decline of plasma HIV-1 RNA. Design: Open-label study in antiretroviral-naive HIV-1 infected patients using a quadruple drug regimen [nelfinavir (NFV)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2028bf69810bd6f6bccacd6894eeac5c
https://doi.org/10.1097/00002030-199811000-00002
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje